Multicenter, randomized controlled trial of traditional Japanese medicine, kakkonto with shosaikotokakikyosekko, for mild and moderate coronavirus disease patients

Overview of attention for article published in Frontiers in Pharmacology, November 2022

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
One of the highest-scoring outputs from this source (#9 of 20,628)
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (99th percentile)

Mentioned by

news: 2 news outlets
twitter: 1340 X users

facebook: 3 Facebook pages
wikipedia: 1 Wikipedia page

Citations

dimensions_citation: 5 Dimensions

Readers on

mendeley: 12 Mendeley

Summary News X Facebook Wikipedia Dimensions citations

So far, Dimensions has found 5 publications that cite this research output.

5

The most recent citing publications are shown below. View all 5 publications that cite this research output on Dimensions.

In vitro anti-severe acute respiratory syndrome coronavirus 2 effect of Ephedra przewalskii Stapf extract

Article in Journal of Ethnopharmacology (October 2023)

背椎脊髄疾患診療における漢方薬の役割

Article in Spinal Surgery (August 2023)

Contribution of traditional Japanese Kampo medicines, kakkonto with shosaikotokakikyosekko, in treating patients with mild-to-moderate coronavirus disease 2019: Further analysis of a multicenter, randomized controlled trial

Article in Journal of Infection and Chemotherapy (July 2023)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.